Trial Profile
Safety and Efficacy of Campath in Nonmyeloablative Transplantation
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary) ; Cyclophosphamide; Fludarabine; Rituximab
- Indications Leukaemia; Lymphoma
- Focus Therapeutic Use
- 25 Jul 2006 New trial record.